Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Pozycja w akcjach #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Cena akcji
$1.58
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$71.95M
Zmiana (1 dzień)
0.64%
Zmiana (1 rok)
-36.29%
Kraj
US
Handel OS Therapies Incorporated (OSTX)

Kategoria

Historia stopy dywidendy dla OS Therapies Incorporated (OSTX)
Stopa dywidendy (TTM) dla OS Therapies Incorporated (symbol akcji: OSTX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla OS Therapies Incorporated (OSTX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji